Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

3 weeks ago 28
Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug Administration request to halt shipments of a gene therapy.
Read Entire Article
  1. Homepage
  2. category-label-
  3. Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

Related

Bitcoin extends rally, hits record high above $124,000

Bitcoin extends rally, hits record high above $124,000

5 hours ago 5
What’s driving ether’s ‘catch-up trade,’ as it nears record high after bitcoin’s streak of peaks

What’s driving ether’s ‘catch-up trade,’ as it nears record ...

8 hours ago 8
Trump-Putin meeting: Here’s what their summit in Alaska could mean for oil prices

Trump-Putin meeting: Here’s what their summit in Alaska coul...

9 hours ago 10

Trending

Popular

XRP Charts Signal Caution to Bulls as Bitcoin Awaits Breakout and Ether Goes Bonkers

XRP Charts Signal Caution to Bulls as Bitcoin Awaits Breakou...

4 days ago 51
DeFi soars with tokenized stocks, but user activity shifts to NFTs: Report

DeFi soars with tokenized stocks, but user activity shifts t...

5 days ago 42
XRP Bull Flag Points to $8 as Ripple-SEC Case Reaches End

XRP Bull Flag Points to $8 as Ripple-SEC Case Reaches End

6 days ago 36
Memecoin-tied trend of sex toys thrown at WNBA games sees 2 arrests

Memecoin-tied trend of sex toys thrown at WNBA games sees 2 ...

6 days ago 36
Bitcoin investment banks coming to El Salvador — Gov regulator

Bitcoin investment banks coming to El Salvador — Gov regulat...

4 days ago 32
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Tayedi Search engine 2025. All rights are reserved